149 related articles for article (PubMed ID: 12517950)
1. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone.
Yin D; Dujovny N; Ma L; Varghese A; Shen J; Bishop DK; Chong AS
J Immunol; 2003 Jan; 170(2):853-60. PubMed ID: 12517950
[TBL] [Abstract][Full Text] [Related]
2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
3. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
Yin D; Ma L; Varghese A; Shen J; Chong AS
J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494
[TBL] [Abstract][Full Text] [Related]
4. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
6. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
7. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy.
Yin D; Ma L; Zeng H; Shen J; Chong AS
Transplantation; 2002 Aug; 74(3):345-54. PubMed ID: 12177612
[TBL] [Abstract][Full Text] [Related]
8. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
Tomura M; Nakatani I; Murachi M; Tai XG; Toyo-oka K; Fujiwara H
Transplantation; 1997 Sep; 64(5):757-63. PubMed ID: 9311716
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
10. Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion.
Isobe M; Suzuki J; Yamazaki S; Yazaki Y; Horie S; Okubo Y; Maemura K; Yazaki Y; Sekiguchi M
Circulation; 1997 Oct; 96(7):2247-53. PubMed ID: 9337197
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
[TBL] [Abstract][Full Text] [Related]
12. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
14. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
15. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway.
Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K
Transplantation; 2001 Nov; 72(9):1556-62. PubMed ID: 11707745
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.
Kurtz J; Shaffer J; Lie A; Anosova N; Benichou G; Sykes M
Blood; 2004 Jun; 103(11):4336-43. PubMed ID: 14962909
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
[TBL] [Abstract][Full Text] [Related]
18. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression.
Adams AB; Durham MM; Kean L; Shirasugi N; Ha J; Williams MA; Rees PA; Cheung MC; Mittelstaedt S; Bingaman AW; Archer DR; Pearson TC; Waller EK; Larsen CP
J Immunol; 2001 Jul; 167(2):1103-11. PubMed ID: 11441122
[TBL] [Abstract][Full Text] [Related]
19. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.
Gorczynski RM; Cohen Z; Leung Y; Chen Z
J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904
[TBL] [Abstract][Full Text] [Related]
20. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
Brown DL; Bishop DK; Wood SY; Cederna PS
Plast Reconstr Surg; 2006 Jun; 117(7):2250-8. PubMed ID: 16772925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
